Andrei Nikiforchin

Dr. Andrei Nikiforchin

Global Medical Knowledge Alliance, Boston, Massachusetts, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
Andrei NikiforchinAndrei Nikiforchin
Andrei Nikiforchin
VGVadim Gushchin
Vadim Gushchin
MKMary Caitlin King
Mary Caitlin King
EBEkaterina Baron
Ekaterina Baron
CNCarol Nieroda
Carol Nieroda
ASArmando Sardi
Armando Sardi

8 February 2022 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
FLFelipe Lopez-Ramirez
Felipe Lopez-Ramirez
VGVadim Gushchin
Vadim Gushchin
MSMichelle Sittig
Michelle Sittig
MKMary Caitlin King
Mary Caitlin King
EBEkaterina Baron
Ekaterina Baron
ASArmando Sardi
Armando Sardi


14 January 2025 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
MAMarta Antoniv
Marta Antoniv
Andrei NikiforchinAndrei Nikiforchin
Andrei Nikiforchin
NSNaomi M Md Sell
Naomi M Md Sell
LBLiliana G Md Bordeianou
Liliana G Md Bordeianou
TFTodd D Md Francone
Todd D Md Francone
RBRonald Bleday
Ronald Bleday
BACKGROUND: Enhanced recovery after surgery (ERAS) protocols aim to improve surgical patient outcomes, although their effectiveness may vary. This study assessed the impact of multi-institutional ERAS implementation on postoperative morbidity in patients undergoing elective colorectal surgery. STUDY DESIGN: We conducted a multicenter retrospective cohort study using the American College of Surgeons NSQIP database from 2012 to 2020. We analyzed patient outcomes before (2012 to 2014) and after (2015 to 2020) ERAS implementation across 4 hospitals. Multivariable logistic regression was used to determine the impact of ERAS program on certain outcomes. RESULTS: A total of 8,930 cases were analyzed: 3,573 in the pre-ERAS and 5,357 in the ERAS cohort. The ERAS cohort demonstrated significant reductions in superficial surgical site infection (SSI; 7.5% vs 2.5%, p < 0.001), deep SSI (0.6% vs 0.2%, p = 0.016), urinary tract infection (3.3% vs 1.5%, p < 0.001), pulmonary embolism (0.7% vs 0.4%, p = 0.022), deep vein thrombosis (1.4% vs 0.9%, p = 0.020), sepsis (3.0% vs 2.1%, p = 0.006), and other complications. Median length of stay decreased from 5 to 4 days (p < 0.001), and 30-day readmission rate dropped from 11.3% to 9.8% (p = 0.022). Overall, ERAS implementation was associated with a 35% decrease in the odds of all 30-day complications (odds ratio 0.65, 95% CI 0.59 to 0.73). There was no effect on 30-day (p = 0.962) or overall mortality rates (p = 0.732). CONCLUSIONS: A standardized ERAS protocol, used across multiple institutions, significantly improves elective colorectal surgery outcomes, reducing complications, length of hospital stay, and readmissions. These findings support the broader implementation of ERAS to enhance patient care and reduce healthcarecosts.

26 August 2023 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
Andrei NikiforchinAndrei Nikiforchin
Andrei Nikiforchin
ASArmando Sardi
Armando Sardi
MKMary Caitlin King
Mary Caitlin King
EBEkaterina Baron
Ekaterina Baron
FLFelipe Lopez-Ramirez
Felipe Lopez-Ramirez
VGVadim Gushchin
Vadim Gushchin